GCG and diabetes mellitus: GLP-1 RA therapy in addition to standard hypoglycemic drugs may reduce the endpoint of hospital admission for HF worsening in a percentage superior of 80%, and increasing with a 3.7 fold the CRTd responders rate in HF patients with diabetes.